RSS-Feed abonnieren
DOI: 10.1055/s-0029-1243205
© Georg Thieme Verlag KG Stuttgart · New York
Animal Models of Primary Aldosteronism
Publikationsverlauf
received 15.09.2009
accepted 09.11.2009
Publikationsdatum:
14. Dezember 2009 (online)

Abstract
Primary aldosteronism is considered the most prevalent form of secondary hypertension with pathophysiological and clinical features different from those of essential hypertension. Despite its high prevalence with the exception of the small subgroup of patients with familial hyperaldosteronism type I, the underlying genetic and molecular basis of this common disease is still largely unknown. In this context animal models can provide important insights in the physiology of aldosterone regulation that can serve as a starting point for investigation of mechanisms involved also in autonomous aldosterone secretion. Mouse models with defined genetic modification can further be utilized to prove functional relevance of these predefined candidate genes. Finally, animal models can be used to investigate cardiovascular and metabolic consequences of unopposed aldosterone secretion and potential restoration of these parameters through pharmacologic interventions. This review will provide a brief overview on animal models currently available for primary aldosteronism and describe in vivo screening strategies that are likely to aid in the elucidation of molecular and genetic mechanisms involved in autonomous aldosterone secretion.
Key words
primary aldosteronism - animal model - knock out mouse - transgenic mouse - aldosterone secretion - renin-angiotensin-aldosterone system
References
- 1
Williams GH, Rose LI, Dluhy RG, Dingman JF, Lauler DP.
Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism.
J Clin Endocrinol Metab.
1971;
32
27-35
MissingFormLabel
- 2
Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP, Allolio B.
Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms:
correlation with P450scc expression.
Clin Endocrinol (Oxf).
1997;
46
619-626
MissingFormLabel
- 3
Himathongkam T, Dluhy RG, Williams GH.
Potassim-aldosterone-renin interrelationships.
J Clin Endocrinol Metab.
1975;
41
153-159
MissingFormLabel
- 4
Burnay MM, Python CP, Vallotton MB, Capponi AM, Rossier MF.
Role of the capacitative calcium influx in the activation of steroidogenesis by angiotensin-II
in adrenal glomerulosa cells.
Endocrinology.
1994;
135
751-758
MissingFormLabel
- 5
Pezzi V, Clyne CD, Ando S, Mathis JM, Rainey WE.
Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and
calmodulin-dependent protein kinases.
Endocrinology.
1997;
138
835-838
MissingFormLabel
- 6
Lu L, Suzuki T, Yoshikawa Y, Murakami O, Miki Y, Moriya T, Bassett MH, Rainey WE, Hayashi Y, Sasano H.
Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex
and its disorders.
J Clin Endocrinol Metab.
2004;
89
4113-4118
MissingFormLabel
- 7
Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE.
The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production.
Mol Endocrinol.
2004;
18
279-290
MissingFormLabel
- 8
Spyroglou A, Manolopoulou J, Wagner S, Bidlingmaier M, Reincke M, Beuschlein F.
Short term regulation of aldosterone secretion after stimulation and suppression experiments
in mice.
J Mol Endocrinol.
2009;
42
407-413
MissingFormLabel
- 9
Brilla CG, Weber KT.
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
J Lab Clin Med.
1992;
120
893-901
MissingFormLabel
- 10
Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouve P, Wassef M, Swynghedauw B, Delcayre C.
Biological determinants of aldosterone-induced cardiac fibrosis in rats.
Hypertension.
1995;
26
971-978
MissingFormLabel
- 11
Young M, Fullerton M, Dilley R, Funder J.
Mineralocorticoids, hypertension, and cardiac fibrosis.
J Clin Invest.
1994;
93
2578-2583
MissingFormLabel
- 12
Brilla CG, Matsubara LS, Weber KT.
Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic
arterial hypertension.
Am J Cardiol.
1993;
71
12A-16A
MissingFormLabel
- 13
Young M, Head G, Funder J.
Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
Am J Physiol.
1995;
269
E657-E662
MissingFormLabel
- 14
Rainey WE, Saner K, Schimmer BP.
Adrenocortical cell lines.
Mol Cell Endocrinol.
2004;
228
23-38
MissingFormLabel
- 15
Yamazaki H, Abe Y, Katoh Y, Sawa N, Ohnishi Y, Tanaka Y, Sasano H, Oshika Y, Tokunaga T, Kijima H, Tamaoki N, Nakamura M, Ueyama Y.
Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism
in vivo.
Apmis.
1998;
106
1056-1060
MissingFormLabel
- 16
Billet S, Bardin S, Verp S, Baudrie V, Michaud A, Conchon S, Muffat-Joly M, Escoubet B, Souil E, Hamard G, Bernstein KE, Gasc JM, Elghozi JL, Corvol P, Clauser E.
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and
cardiovascular fibrosis in mice.
J Clin Invest.
2007;
117
1914-1925
MissingFormLabel
- 17
Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, Abdullah U, Krippeit-Drews P, Feil R, Hofmann F, Knaus HG, Kenyon C, Shipston MJ, Storm JF, Neuhuber W, Korth M, Schubert R, Gollasch M, Ruth P.
Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation
in BK channel-deficient mice.
Circulation.
2005;
112
60-68
MissingFormLabel
- 18
Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ.
TASK channel deletion in mice causes primary hyperaldosteronism.
Proc Natl Acad Sci U S A.
2008;
105
2203-2208
MissingFormLabel
- 19
Czirjak G, Fischer T, Spat A, Lesage F, Enyedi P.
TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of
rat adrenal cortex and inhibited by angiotensin II.
Mol Endocrinol.
2000;
14
863-874
MissingFormLabel
- 20
Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R, Reichold M, Tegtmeier I, Bendahhou S, Gomez-Sanchez CE, Aller MI, Wisden W, Weber A, Lesage F, Warth R, Barhanin J.
Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid
homeostasis.
Embo J.
2008;
27
179-187
MissingFormLabel
- 21
Bandulik S, Penton D, Barhanin J, Warth R.
TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical
zonation
Horm Metab Res.
in press
MissingFormLabel
- 22
Romero DG, Yanes LL, de Rodriguez AF, Plonczynski MW, Welsh BL, Reckelhoff JF, Gomez-Sanchez EP, Gomez-Sanchez CE.
Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone
secretion.
Endocrinology.
2007;
148
2644-2652
MissingFormLabel
- 23
Sheng Z, Sun W, Smith E, Cohen C, Xu XX.
Restoration of positioning control following Disabled-2 expression in ovarian and
breast tumor cells.
Oncogene.
2000;
19
4847-4854
MissingFormLabel
- 24
Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX.
Disabled-2 is an epithelial surface positioning gene.
J Biol Chem.
2007;
282
13114-13122
MissingFormLabel
- 25
Romero DG, Plonczynski MW, Welsh BL, Gomez-Sanchez CE, Zhou MY, Gomez-Sanchez EP.
Gene expression profile in rat adrenal zona glomerulosa cells stimulated with aldosterone
secretagogues.
Physiol Genomics.
2007;
32
117-127
MissingFormLabel
- 26
Javadi S, Djajadiningrat-Laanen SC, Kooistra HS, van Dongen AM, Voorhout G, van Sluijs FJ, van den Ingh TS, Boer WH, Rijnberk A.
Primary hyperaldosteronism, a mediator of progressive renal disease in cats.
Domest Anim Endocrinol.
2005;
28
85-104
MissingFormLabel
- 27
Russell LB, Montgomery CS.
Supermutagenicity of ethylnitrosourea in the mouse spot test: comparisons with methylnitrosourea
and ethylnitrosourethane.
Mutat Res.
1982;
92
193-204
MissingFormLabel
- 28
Popp RA, Bailiff EG, Skow LC, Johnson FM, Lewis SE.
Analysis of a mouse alpha-globin gene mutation induced by ethylnitrosourea.
Genetics.
1983;
105
157-167
MissingFormLabel
- 29
Grunwald DJ, Streisinger G.
Induction of recessive lethal and specific locus mutations in the zebrafish with ethyl
nitrosourea.
Genet Res.
1992;
59
103-116
MissingFormLabel
- 30
Rinchik EM.
Chemical mutagenesis and fine-structure functional analysis of the mouse genome.
Trends Genet.
1991;
7
15-21
MissingFormLabel
- 31
Manolopoulou J, Bielohuby M, Caton SJ, Gomez-Sanchez CE, Renner-Mueller I, Wolf E, Lichtenauer UD, Beuschlein F, Hoeflich A, Bidlingmaier M.
A highly sensitive immunofluorometric assay for the measurement of aldosterone in
small sample volumes: validation in mouse serum.
J Endocrinol.
2008;
196
215-224
MissingFormLabel
Correspondence
F. Beuschlein
Endocrine Research Unit
Medizinische Klinik-Innenstadt
Ludwig-Maximilians-University
Ziemssenstraße 1
80336 Munich
Germany
Telefon: +49 89 5160 2110
Fax: +49 89 5160 4467
eMail: felix.beuschlein@med.uni-muenchen.de